All lobbying filings
Novocure Inc.
Novocure Inc. filed a Q2 report for Novocure Inc. on July 15, 2025.
Lobbying for Novocure Inc.
Filing · LD-2 quarterly report
Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 15, 2025
Expenses
$110,000
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
Pennsylvania
Lobbyists on this filing
2
-
KATHERINE MEYERPreviously held: Senior Policy Advisor, Office of House Republican Leader Kevin McCarthy; Deputy Health Policy Director, Senate Finance Committee; Health Policy Advisor, Senator Orrin Hatch; Sr. LA, Congressman Erik Paulsen; LA, Congressman Jeff Fortenberry
-
ELLE WHITSONPreviously held: Covered Official Positions Continued: Health Policy Advisor, Congresswoman Cathy McMorris Rogers; Staff Assistant / Legislative Correspondent / Legislative Assistant, Congressman Ryan Costello
Government bodies contacted
3
Lobbying activity
2
General Medicare Issues. S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Veterans Affairs / Veterans Health Administration (VHA) issues.
Bills named in this filing
1